LARONI, ALICE
 Distribuzione geografica
Continente #
NA - Nord America 167
EU - Europa 100
AS - Asia 40
OC - Oceania 21
AF - Africa 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 334
Nazione #
US - Stati Uniti d'America 163
IT - Italia 41
GB - Regno Unito 25
VN - Vietnam 22
AU - Australia 21
IN - India 8
DE - Germania 5
FR - Francia 5
NL - Olanda 4
CI - Costa d'Avorio 3
DK - Danimarca 3
JP - Giappone 3
MX - Messico 3
AT - Austria 2
IR - Iran 2
PT - Portogallo 2
QA - Qatar 2
RO - Romania 2
RU - Federazione Russa 2
A2 - ???statistics.table.value.countryCode.A2??? 1
CA - Canada 1
CH - Svizzera 1
CN - Cina 1
CZ - Repubblica Ceca 1
ES - Italia 1
GR - Grecia 1
HU - Ungheria 1
IE - Irlanda 1
MD - Moldavia 1
NG - Nigeria 1
PL - Polonia 1
SY - Repubblica araba siriana 1
TR - Turchia 1
UA - Ucraina 1
ZA - Sudafrica 1
Totale 334
Città #
Houston 21
Dong Ket 19
Santa Cruz 16
Fairfield 14
Torino 14
Ann Arbor 12
San Diego 9
Buffalo 7
New Delhi 6
Wilmington 6
Ashburn 5
Manchester 5
Seattle 5
Conegliano 4
Fleming Island 4
Gosford 4
London 4
Woodbridge 4
Abidjan 3
Bedford 3
Valley View 3
Brisbane 2
Carnaxide 2
Doha 2
Mexico City 2
Milan 2
Rome 2
Union City 2
Vienna 2
Aidenbach 1
Amsterdam 1
Athens 1
Boardman 1
Brockport 1
Brookville 1
Buccinasco 1
Cagliari 1
Cambridge 1
Coimbatore 1
Columbus 1
Copenhagen 1
Council Bluffs 1
Crugers 1
Dresden 1
Dublin 1
Enfield 1
Galati 1
Gazzada 1
Genoa 1
Genova 1
Germantown 1
Groningen 1
Gurgaon 1
Henderson 1
Istanbul 1
Kish 1
Lagos 1
Langhorne 1
Las Vegas 1
Miami 1
Mountain View 1
Muizenberg 1
Naaldwijk 1
Nanning 1
Napoli 1
Nottwil 1
Novara 1
Ottawa 1
Provo 1
Reus 1
Riva 1
Rockville 1
Saint Petersburg 1
Scranton 1
Tamworth 1
Tlalnepantla 1
Tokyo 1
Treviso 1
Twisk 1
Udine 1
Velletri 1
Warsaw 1
Washington 1
Totale 238
Nome #
A real-world study of Alemtuzumab in a cohort of Italian patients, file e27ce430-8a4a-2581-e053-d805fe0acbaa 98
Comparative effectiveness of dimethyl fumarate, teriflunomide, interferon-beta and glatiramer acetate on newly diagnosed patients: a propensity score-matched analysis from a multicenter Italian group, file e27ce430-e62c-2581-e053-d805fe0acbaa 80
Assessing association of comorbidities with treatment choice and persistence in MS: A real-life multicenter study, file e27ce433-d8da-2581-e053-d805fe0acbaa 50
Cladribine vs other drugs in MS: Merging randomized trial with real-life data, file e27ce430-ce89-2581-e053-d805fe0acbaa 47
Determinants of therapy switch in multiple sclerosis treatment-naïve patients: A real-life study, file e27ce434-2a05-2581-e053-d805fe0acbaa 29
Comparative effectiveness of Cladribine tablets vs other drugs in relapsing-remitting multiple sclerosis: an approach merging randomized controlled trial with real life data, file e27ce430-be5b-2581-e053-d805fe0acbaa 11
Shift from fingolimod to alemtuzumab: what happens next?, file e27ce430-82b1-2581-e053-d805fe0acbaa 9
Extended interval dosing of natalizumab: is efficacy preserved?, file e27ce430-82b2-2581-e053-d805fe0acbaa 7
Switching to alemtuzumab from fingolimod or other therapies: impact of wash-out period on disease activity, file e27ce430-e700-2581-e053-d805fe0acbaa 7
Assessing association of comorbidities with treatment choice and persistence in MS: A real-life multicenter study, file e27ce432-53ae-2581-e053-d805fe0acbaa 7
A Real-Life Study of Alemtuzumab: Impact of Previous Therapies and Washout Period on Disease Activity, file e27ce430-9a8d-2581-e053-d805fe0acbaa 6
Determinants of therapy switch in multiple sclerosis treatment-naïve patients: A real-life study, file e27ce432-5b0c-2581-e053-d805fe0acbaa 5
Totale 356
Categoria #
all - tutte 539
article - articoli 0
book - libri 0
conference - conferenze 343
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 882


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202149 0007 10 67 41518
2021/2022192 12122931 249 713 318268
2022/2023115 7123324 1511 130 0000
Totale 356